Back to mobile site

NervGen delists from TSX Venture Exchange, continues on NASDAQ

March 12, 2026 4:15 PM EDT Send to a Friend
NervGen Pharma Corp. (NASDAQ: NGEN) announced it will voluntarily delist its common shares from the TSX Venture Exchange, effective at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login